|Articles|December 4, 2013
The Impact of Biosimilars on the Innovator Market
Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing
Advertisement
Jill E. Sackman, D.V.M., PhD, senior consultant atNumerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing.
For more videos tune in to:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5